Skip to main content

The Globe and Mail

Paladin CEO in hospital following accident

Jonathan Goodman, Ceo pf Paladin Labs Inc.

Pierre Charbonneau/The Globe and Mail

Paladin Labs Inc. the Montreal-based pharmaceutical company that earlier this week announced the take-over of drug-maker Labopharm Inc. , said Thursday that its president and chief executive officer Jonathan Goodman is in hospital with serious injuries after an accident.

The company did not reveal what kind of accident was involved, but the injuries are serious, and are still being assessed, it said.

Paladin's board has appointed Mark Beaudet, a co-founder of the company and currently vice-president of sales, to take Mr. Goodman's place as CEO for the time being.

Story continues below advertisement

As well as the bid for Labopharm, Paladin also recent proposed a takeover of Afexa Life Sciences Inc., the Edmonton company that makes COLD-FX.

In a statement Mr. Beaudet said the management team will continue to advance all of the company's on-going projects.

Mr. Goodman founded Paladin in 1996. It now distributes dozens of pharmaceutical products in Canada and other countries, ranging from prostate cancer treatments to birth control pills to wart medications.

Report an error Licensing Options
About the Author
Reporter, Report on Business

Richard Blackwell has reported on Canadian business for more than three decades. At the Financial Post and the Globe and Mail he has covered technology, transportation, investing, banking, securities and media, among many other subjects. Currently, his focus is on green technology and the economy. More

Comments are closed

We have closed comments on this story for legal reasons. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.